Skip to content

Clinical trials

Completed Phase 2 Reperfusion Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Phase 2 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20071
20082
20091
20122
20131
20142
20152
20181
20201
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dompé Farmaceutici S.p.A2
Alavita Pharmaceuticals Inc1
Amosov National Institute of Cardiovascular Surgery1
Asan Medical Center1
Barts & The London NHS Trust1
Herlev Hospital1
Hospices Civils de Lyon1
Johns Hopkins University1
Martin Andreas, M.D.1
Medicure1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury21
Myocardial Ischemia4
ST Elevation Myocardial Infarction4
Acute Kidney Injury2
Myocardial Infarction2
Myocardial Reperfusion Injury2
Acute Coronary Syndrome1
Aortic Valve Stenosis1
Cardiovascular Diseases1
Heart Valve Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.